G218A (p.Gly218Ala) variant of MED13L (Q71F56)
G218A (p.Gly218Ala) in MED13L (Q71F56) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.22 / 1. The record also includes structural context.
G218A (p.Gly218Ala) variant details
- p.Gly218Ala
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.219
- ESM-1b 0.00
- AlphaMissense 0.59
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available